Fang Wu

19PUBLICATIONS
67CO-AUTHORS
Cancer diagnosisPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCardiology (incl. cardiovascular diseases)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jan 14, 2025
Optimizing the NGS-based discrimination of multiple lung cancers from the perspective of evolution.

Ziyang Wang, Xiaoqiu Yuan, Kunkun Sun

|Aug 07, 2024
Pretreatment pulmonary tumor necrosis is a promising prognostic imaging biomarker for first-line anti-PD-1/PD-L1 therapy in advanced lung squamous cell carcinoma: a multi-institutional, propensity score-matching cohort analysis.

Qiaofeng Zhong, Longfeng Zhang, Lin Wu

|May 13, 2024
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer.

Yue Zeng, Chun-Hong Hu, Yi-Zheng Li

|Jan 14, 2024
Rechallenge of immune checkpoint inhibitors in advanced non-small cell lung cancer.

Gen Lin, Zhijie Wang, Qian Chu

|Nov 14, 2023
Clinical definition of secondary resistance to immunotherapy in non-small cell lung cancer.

Dingzhi Huang, Gen Lin, Qian Chu

|Sep 18, 2023
Expert consensus on the diagnosis and treatment of RET gene fusion non-small cell lung cancer in China.

Xingxiang Pu, Chunwei Xu, Qian Wang

Pageof 4

Frequent Collaborators

3 joint publications

Tangfeng Lv

3 joint publications

Jisheng Li

3 joint publications

Wenzhao Zhong

3 joint publications

Chengzhi Zhou